Article: Dutasteride for androgenetic alopecia.(WASHINGTON WHISPERS)(Clinical report)

Dutasteride for Androgenetic Alopecia

Commentary on:

The importance of dual 5 alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. Olsen EA, et al. J Am Acad Dermatol. 2006;55:1014-1023.

Summary

The authors report a phase II, multicenter, randomized, double-blinded, placebo-controlled study assessing the efficacy of dutasteride at 4 different doses compared to finasteride in the treatment of androgenetic alopecia. Inclusion criteria included men aged 21 to 45 years with mild to moderate male pattern hair loss (Hamilton-Norwood ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!